PHLEBOVIRUS-BASED VECTOR VACCINES FOR CANCER IMMUNOTHERAPY

摘要

The invention relates to a Phlebovirus-based vector, whereby a gene encoding a tumor-associated antigen is functionally inserted into the genome of said Phlebovirus, and to methods of ameliorating and/or treating an individual suffering from a tumor, comprising administering said Phlebovirus-based vector to said individual.